CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. — Form 8-K
Filed September 25, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
Creative Medical Technology Holdings (CMTH) purchased 4,000,000 shares of BioDefense, Inc. common stock from Creative Acquisition Corp. on September 24, 2026. Consideration: $200,000 cash plus 1,000,000 CMTH shares (unspecified valuation). Post-closing: CMTH owns 16M BioDefense shares (67% of transaction 4M shares); seller retains 4M shares.
Why this rating
Acquisition cost ~$200K cash is 4% of CMTH's $4.6M market cap; issuance of 1M new shares dilutes existing shareholders but valuation not disclosed. Material but unproven strategic value in undisclosed target company.
Price action (we called it neutral)
before filing · preread $0.98 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 25, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.